Send Email
Send SMS
Search
D. Vijay Pharma Private Limited
D. Vijay Pharma Private Limited


Life Saving Drugs

We engage in distribution and supply of a wide range of Life Saving Drugs.All the drugs are directly sourced from Manufacturer, hence no chance of Counterfeit Drugs. All these products are offered with multiple company choice with variable price range.

 Our range includes cardio- Diabetic drugs,Anti Snake Venom, AGGS and other Life Saving Drugs. We deal in companies like Boehringer Ingelheim, Abbott, Novartis, Nicholas piramal etc. 

Pentaglobin 250 Mg Injection

REQUEST CALLBACK

Pentaglobin 250 Mg Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 5,172 / BottleGet Latest Price

Product Details:
BrandBiotest
Usage/ApplicationClinical
CompositionPentaglobin
Injectable FormLiquid
Dose250 mg
Packaging Size10 ml
Medicine TypeInjection
Product TypeFinished Product
GenderUnisex

We offer Pentaglobin 250 Mg Injection to our clients.

Active ingredient:
  • Human immunoglobulin for intravenous administration Store protected from light at +2 Degree C to 8 Degree C Keep out of reach of children I Approved by th german health authorities

Additional Information:

  • Item Code: 13183
  • Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),D/P,UPI PAYMENT
  • Port of Dispatch: Mumbai, India
  • Packaging Details: 2 to 8 Degrees Cold Chain Product
  • Yes! I am interested

    Mozifor 1.2ml ( Plexrixafor) Injection

    REQUEST CALLBACK

    Mozifor 1.2ml ( Plexrixafor) Injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 23,700 / PackGet Latest Price

    Product Details:
    Minimum Order Quantity1 Pack
    BrandHetero
    Usage/ApplicationPersonal
    CompositionPlexrixafor
    Injectable FormLiquid
    Dose1.2ml
    Packaging SizeVial
    Medicine TypeInjection
    Product TypeFinished Product
    GenderUnisex
    Packaging TypeBox
    Power1.2Ml Injection
    Shelf Life25 Months

    Mozobil (plerixafor) injection is a sterile, preservative-free, clear, colorless to pale-yellow, isotonic solution for subcutaneous injection. Each mL of the sterile solution contains 20 mg of plerixafor. Each single-use vial is filled to deliver 1.2 mL of the sterile solution that contains 24 mg of plerixafor and 5.9 mg of sodium chloride in Water for Injection adjusted to a pH of 6.0 to 7.5 with hydrochloric acid and with sodium hydroxide, if required.

    Plerixafor is a hematopoietic stem cell mobilizer with a chemical name l, 1’-[1,4phenylenebis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane. It has the molecular formula C28H54N8. The molecular weight of plerixafor is 502.79 g/mol.

    Mozobil®(plerixafor) injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM).

    Recommended Dosage And Administration

    Vials should be inspected visually for particulate matter and discoloration prior to administration and should not be used if there is particulate matter or if the solution is discolored.

    Begin treatment with Mozobil after the patient has received G-CSF once daily for four days [see Recommended Concomitant Medications]. Administer Mozobil approximately 11 hours prior to initiation of each apheresis for up to 4 consecutive days.

    The recommended dose of Mozobil by subcutaneous injection is based on body weight:

    • 20 mg fixed dose or 0.24 mg/kg of body weight for patients weighing ≤83 kg. [see CLINICAL PHARMACOLOGY]
    • 0.24 mg/kg of body weight for patients weighing >83 kg.

    Use the patient’s actual body weight to calculate the volume of Mozobil to be administered. Each vial delivers 1.2 mL of 20 mg/mL solution, and the volume to be administered to patients should be calculated from the following equation:

    0.012 × patient’s actual body weight (in kg) = volume to be administered (in mL)

    In clinical studies, Mozobil dose has been calculated based on actual body weight in patients up to 175% of ideal body weight. Mozobil dose and treatment of patients weighing more than 175% of ideal body weight have not been investigated.

     

    Based on increasing exposure with increasing body weight, the Mozobil dose should not exceed 40 mg/day.



    Additional Information:

  • Item Code: 16280
  • Delivery Time: Depends on location
  • Yes! I am interested

    Factor Eight Injection

    REQUEST CALLBACK

    Factor Eight Injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 3,700 / UnitGet Latest Price

    Product Details:
    Minimum Order Quantity1 Unit
    BrandBaxter
    Usage/ApplicationClinical
    CompositionPlasma and Serum Glycoprotein involved in blood coagulation
    Injectable FormLyophilized Powder
    Medicine TypeAllopathic
    Form Of MedicineInjectable

    Factor 8 is indicated for replacement therapy in patients with von Willebrand's disease in whom factor VIII activity is reduced. Replacement therapy with Factor to control haemorrhages and to prevent bleeding episodes associated with surgical interventions follows the guidelines given for haemophilia A.

    Human coagulation factor VIII is a preparation of plasma protein fraction that contains the glycoprotein coagulation factor VIII (plasma and serum glycoprotein involved in blood coagulation) together with varying amounts of Willebrand factor, depending on the method of preparation

    Foreign Names
    • Factor VIII coagulationis sanguinis humanus (Latin)
    • Blutgerinnungsfaktor VIII vom Menschen (German)
    • Facteur VIII de coagulation sanguine humain (French)
    • Factor VIII de coagulacion sanguinea humana (Spanish)
    Yes! I am interested

    Cafirate Injection

    REQUEST CALLBACK

    Cafirate Injection
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Product Details:
    UsageClinical and Hospital
    Packaging TypeGlass Bottle
    Medicine TypeAllopathic
    CompositionCaffeine Citrate Injection USP
    Dose20 mg/3 ml

    We offer Cafirate Injection to our clients.

    Other Details:
    • For IV use only

    Additional Information:

  • Item Code: 11456
  • Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),D/P
  • Port of Dispatch: Mumbai, India
  • Packaging Details: Room Temperature Product
  • Yes! I am interested

    Pradaxa Capsules

    REQUEST CALLBACK

    Pradaxa Capsules
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Product Details:
    ManufacturerBOHRINGER INGHELIUM
    TreatmentFOR DIABETICS
    Prescription/Non prescriptionPrescription
    Product TypeFinished Product
    UsageHospital, Personal, Clinical
    Packaging Size6 x 10 Capsules
    FormTablet
    CompositionDabigatran Etexilate mesilate
    Available Dose110,150 mg

    We offer Pradaxa Capsules to our clients.

    Additional Information:

  • Item Code: 14092
  • Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),D/P,UPI PAYMENT
  • Port of Dispatch: Mumbai, India
  • Packaging Details: Room Temperature Product
  • Yes! I am interested

     
    X


    Explore More Products

    Contact via E-mail
    Contact via SMS
    D. Vijay Pharma Private Limited
    Jimit Bhinde (Marketing Manager)
    Unit No. 11, Shilpin Center, GD Ambedkar Road , Dadar East,
    Mumbai - 420031, Maharashtra, India
    Call Us: 
    Call Response Rate: 86%
    Share Us :
    F G T L



    Home  |   Profile   |  Our Products  |  Site Map  |   Contact Us

    © D. Vijay Pharma Private Limited. All Rights Reserved (Terms of Use)
    Developed and Managed by IndiaMART InterMESH Limited

    D. Vijay Pharma Private Limited